Logo
x

Search

Subscribe Now

Pediatric patients

Merck's Keytruda (pembrolizumab) Receives the EC's Approval in Adults & Pediatric patients with R/R cHL

Merck's Keytruda (pembrolizumab) Receives the EC's Approval in Adults & Pediatric patients with R/R cHL

  • March 18, 2021
Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

  • March 3, 2021
CSL Behring's Haegarda (C1 Esterase Inhibitor) Receives the US FDA's Approval for Pediatric Patients with Hereditary Angioedema

CSL Behring's Haegarda (C1 Esterase Inhibitor) Receives the US FDA's Approval for Pediatric Patients with Hereditary Angioedema

  • September 29, 2020
AbbVie Reports the US FDA's Acceptance of BOTOX's sBLA for Pediatric Patients with Neurogenic Detrusor Overactivity

AbbVie Reports the US FDA's Acceptance of BOTOX's sBLA for Pediatric Patients with Neurogenic Detrusor Overactivity

  • June 23, 2020
Gilead to Initiate P-II/III Study Evaluating Remdesivir in Pediatric Patients Hospitalized With COVID-19

Gilead to Initiate P-II/III Study Evaluating Remdesivir in Pediatric Patients Hospitalized With COVID-19

  • June 18, 2020
Tolmar's Fensolvi Received the US FDA's Approval to Treat Pediatric Patients Two Years of Age and Older withntral Prec Ceocious Puberty (CPP)

Tolmar's Fensolvi Received the US FDA's Approval to Treat Pediatric Patients Two Years of Age and Older withntral Prec Ceocious Pu...

  • May 4, 2020
Ironwood Pharmaceuticals’ Linzess (linaclotide) Receives the US FDA’s Approval for the Treatment of Functional Constipation in Pediatric Patients Aged 6-17 Years

    Ironwood Pharmaceuticals’ Linzess (linaclotide) Receives the US FDA’s Approval for the Treatment of Functional Constipation in Ped...

    • June 13, 2023
    BeiGene’s Blincyto (blinatumomab) Receives the NMPA’s Approval for Pediatric Patients with Relapsed or Refractory B-Cell Precursor ALL

      BeiGene’s Blincyto (blinatumomab) Receives the NMPA’s Approval for Pediatric Patients with Relapsed or Refractory B-Cell Precursor...

      • May 4, 2022
      Merck

        Merck's Keytruda (pembrolizumab) Receives the EC's Approval in Adults & Pediatric patients with R/R cHL

        • March 18, 2021
        Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

          Amgen Reports Results of Blincyto (blinatumomab) in P-III Study for Relapsed Acute Lymphoblastic Leukemia in Pediatric Patients

          • March 3, 2021
          CSL Behring

            CSL Behring's Haegarda (C1 Esterase Inhibitor) Receives the US FDA's Approval for Pediatric Patients with Hereditary Angioedema

            • September 29, 2020
            AbbVie Reports the US FDA

              AbbVie Reports the US FDA's Acceptance of BOTOX's sBLA for Pediatric Patients with Neurogenic Detrusor Overactivity

              • June 23, 2020
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.